Jiang W - Search Results

1

Novel cathepsin K inhibitors block osteoclasts in vitro and increase spinal bone density in zebrafish.

Xue ST, Wang YL, Han XW, Yi H, Jiang W, Si SY, Guo HF, Li ZR. Xue ST, et al. Among authors: jiang w. RSC Adv. 2019 Mar 14;9(15):8600-8607. doi: 10.1039/c8ra10338k. eCollection 2019 Mar 12. RSC Adv. 2019. PMID: 35518710 Free PMC article.

2

A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats.

Han X, Gong S, Li N, Wang X, Liu P, Xu Y, He X, Jiang W, Si S. Han X, et al. Among authors: jiang w. Front Pharmacol. 2019 Mar 11;10:103. doi: 10.3389/fphar.2019.00103. eCollection 2019. Front Pharmacol. 2019. PMID: 30914947 Free PMC article.

3

Ahmpatinin ⁱBu, a new HIV-1 protease inhibitor, from Streptomyces sp. CPCC 202950.

Chen MH, Chang SS, Dong B, Yu LY, Wu YX, Wang RZ, Jiang W, Gao ZP, Si SY. Chen MH, et al. Among authors: jiang w. RSC Adv. 2018 Jan 30;8(10):5138-5144. doi: 10.1039/c7ra13241g. eCollection 2018 Jan 29. RSC Adv. 2018. PMID: 35542440 Free PMC article.

4

Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening.

Fu DH, Jiang W, Zheng JT, Zhao GY, Li Y, Yi H, Li ZR, Jiang JD, Yang KQ, Wang Y, Si SY. Fu DH, et al. Among authors: jiang jd, jiang w. Mol Cancer Ther. 2008 Aug;7(8):2386-93. doi: 10.1158/1535-7163.MCT-08-0035. Mol Cancer Ther. 2008. PMID: 18723485

5

DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1.

Zhang J, Li Y, Guo L, Cao R, Zhao P, Jiang W, Ma Q, Yi H, Li Z, Jiang J, Wu J, Wang Y, Si S. Zhang J, et al. Among authors: jiang w, jiang j. Cancer Biol Ther. 2009 Dec;8(24):2374-83. doi: 10.4161/cbt.8.24.10182. Epub 2009 Dec 27. Cancer Biol Ther. 2009. PMID: 19855194

6

A new trichostatin analog from Streptomyces sp. CPCC 203909.

Chen MH, Wu YX, Xu YN, Liu P, Yu LY, Hong B, Jiang W, Si SY. Chen MH, et al. Among authors: jiang w. J Asian Nat Prod Res. 2015;17(6):676-82. doi: 10.1080/10286020.2015.1042372. Epub 2015 May 15. J Asian Nat Prod Res. 2015. PMID: 25977996

7

E17110 promotes reverse cholesterol transport with liver X receptor β agonist activity in vitro.

Li N, Wang X, Liu P, Lu D, Jiang W, Xu Y, Si S. Li N, et al. Among authors: jiang w. Acta Pharm Sin B. 2016 May;6(3):198-204. doi: 10.1016/j.apsb.2016.03.005. Epub 2016 Apr 5. Acta Pharm Sin B. 2016. PMID: 27175330 Free PMC article.

8

IMB-T130 targets 3-dehydroquinate synthase and inhibits Mycobacterium tuberculosis.

Zhu N, Wang X, Li D, Lin Y, You X, Jiang J, Xu Y, Jiang W, Si S. Zhu N, et al. Among authors: jiang w, jiang j. Sci Rep. 2018 Nov 28;8(1):17439. doi: 10.1038/s41598-018-35701-z. Sci Rep. 2018. PMID: 30487577 Free PMC article.

9

Characterization of the isoflavone pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells.

Yang Y, Jiang W, Wang L, Zhang ZB, Si SY, Hong B. Yang Y, et al. Among authors: jiang w. Biol Pharm Bull. 2009 Jul;32(7):1289-94. doi: 10.1248/bpb.32.1289. Biol Pharm Bull. 2009. PMID: 19571401 Free article.

10

Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase.

Zhu N, Lin Y, Li D, Gao N, Liu C, You X, Jiang J, Jiang W, Si S. Zhu N, et al. Among authors: jiang w, jiang j. J Antimicrob Chemother. 2015 Aug;70(8):2287-94. doi: 10.1093/jac/dkv110. Epub 2015 May 9. J Antimicrob Chemother. 2015. PMID: 25957580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,137 results

Search Page